These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical and microbiological features of cryptococcal meningitis. Hasimoto e Souza LK; Costa CR; Fernandes Ode F; Abrão FY; Silva TC; Treméa CM; Silva Mdo R Rev Soc Bras Med Trop; 2013; 46(3):343-7. PubMed ID: 23856876 [TBL] [Abstract][Full Text] [Related]
25. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Pappas PG; Perfect JR; Cloud GA; Larsen RA; Pankey GA; Lancaster DJ; Henderson H; Kauffman CA; Haas DW; Saccente M; Hamill RJ; Holloway MS; Warren RM; Dismukes WE Clin Infect Dis; 2001 Sep; 33(5):690-9. PubMed ID: 11477526 [TBL] [Abstract][Full Text] [Related]
26. Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus. Lortholary O; Dromer F; Mathoulin-Pélissier S; Fitting C; Improvisi L; Cavaillon JM; Dupont B; J Infect Dis; 2001 Jan; 183(2):294-302. PubMed ID: 11110651 [TBL] [Abstract][Full Text] [Related]
27. Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status. Brizendine KD; Baddley JW; Pappas PG PLoS One; 2013; 8(3):e60431. PubMed ID: 23555970 [TBL] [Abstract][Full Text] [Related]
28. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients]. Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893 [TBL] [Abstract][Full Text] [Related]
29. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. Lortholary O; Poizat G; Zeller V; Neuville S; Boibieux A; Alvarez M; Dellamonica P; Botterel F; Dromer F; Chêne G AIDS; 2006 Nov; 20(17):2183-91. PubMed ID: 17086058 [TBL] [Abstract][Full Text] [Related]
30. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy. Sun HY; Chen MY; Hsiao CF; Hsieh SM; Hung CC; Chang SC Clin Microbiol Infect; 2006 Apr; 12(4):381-8. PubMed ID: 16524416 [TBL] [Abstract][Full Text] [Related]
31. Disseminated Cryptococcosis presenting as cellulitis in a renal transplant recipient. Chaya R; Padmanabhan S; Anandaswamy V; Moin A J Infect Dev Ctries; 2013 Jan; 7(1):60-3. PubMed ID: 23324822 [TBL] [Abstract][Full Text] [Related]
33. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis. Chiu SK; Lin JC; Wang NC; Peng MY; Chang FY J Microbiol Immunol Infect; 2008 Aug; 41(4):286-93. PubMed ID: 18787734 [TBL] [Abstract][Full Text] [Related]
34. [Cryptococcosis in AIDS patients: a study of 19 cases]. Gazapo Carretero E; García Aguado C; Adrados de Llano M; Martínez Blanco ML; Verdejo Ortes J; González Lahoz JM Rev Clin Esp; 1992 May; 190(9):450-4. PubMed ID: 1626090 [TBL] [Abstract][Full Text] [Related]
35. Risk factors for mortality from primary cryptococcosis in patients with HIV. Sajadi MM; Roddy KM; Chan-Tack KM; Forrest GN Postgrad Med; 2009 Mar; 121(2):107-13. PubMed ID: 19332968 [TBL] [Abstract][Full Text] [Related]
36. Cryptococcosis in Colombia: results of the national surveillance program for the years 2006-2010. Escandón P; de Bedout C; Lizarazo J; Agudelo CI; Tobón A; Bello S; Restrepo A; Castañeda E; Biomedica; 2012 Sep; 32(3):386-98. PubMed ID: 23715187 [TBL] [Abstract][Full Text] [Related]
37. Cryptococcosis in the immunocompromised host with special reference to AIDS. Khanna N; Chandramuki A; Desai A; Ravi V; Santosh V; Shankar SK; Satishchandra P Indian J Chest Dis Allied Sci; 2000; 42(4):311-5. PubMed ID: 15597679 [TBL] [Abstract][Full Text] [Related]